IPEX as a Result of Mutations in FOXP3

od van der Vliet, Hans J. J., Nieuwenhuis, Edward E.
Izdano 2007

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

od King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Izdano u Front Immunol (2018)

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

od King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Izdano u Front Immunol (2018)

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression

od Stolk, Dorian, van der Vliet, Hans J., de Gruijl, Tanja D., van Kooyk, Yvette, Exley, Mark A.
Izdano u Front Immunol (2018)

Hepatitis C Virus (HCV)-Specific CD8(+) Cells Produce Transforming Growth Factor β That Can Suppress HCV-Specific T-Cell Responses

od Alatrakchi, Nadia, Graham, Camilla S., van der Vliet, Hans J. J., Sherman, Kenneth E., Exley, Mark A., Koziel, Margaret James
Izdano 2007

Circulating Myeloid Dendritic Cells of Advanced Cancer Patients Result in Reduced Activation and a Biased Cytokine Profile in Invariant NKT Cells

od van der Vliet, Hans J. J., Wang, Ruojie, Yue, Simon C., Koon, Henry B., Balk, Steven P., Exley, Mark A.
Izdano 2008

Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma

od HADJ, JAMAL OULAD, BRAVEN, ROGIER DEN, TILLIER, CORRINE, SCHRIJVER, HANS M., VERHEUL, HENK M.W., VAN DER VLIET, HANS J.
Izdano 2012

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

od Veluchamy, John P., Kok, Nina, van der Vliet, Hans J., Verheul, Henk M. W., de Gruijl, Tanja D., Spanholtz, Jan
Izdano u Front Immunol (2017)

Irinotecan-Induced Dysarthria

od Dressel, Albertine J., van der Mijn, Johannes C., Aalders, IJke J., Rinkel, Rico N.P.M., van der Vliet, Hans J.
Izdano 2012

Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy

od Werter, Inge M., Schneiders, Famke L., Scotet, Emmanuel, Verheul, Henk M.W., de Gruijl, Tanja D., van der Vliet, Hans J.
Izdano u Oncoimmunology (2014)

Immunological effects of everolimus in patients with metastatic renal cell cancer

od Huijts, Charlotte M, Santegoets, Saskia J, de Jong, Tamarah D, Verheul, Henk M, de Gruijl, Tanja D, van der Vliet, Hans J
Izdano u Int J Immunopathol Pharmacol (2017)

Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

od Kim, Jong Yeob, Kronbichler, Andreas, Eisenhut, Michael, Hong, Sung Hwi, van der Vliet, Hans J., Kang, Jeonghyun, Shin, Jae Il, Gamerith, Gabriele
Izdano u Cancers (Basel) (2019)

Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials

od Kim, Jong Yeob, Lee, Keum Hwa, Eisenhut, Michael, van der Vliet, Hans J., Kronbichler, Andreas, Jeong, Gwang Hun, Shin, Jae Il, Gamerith, Gabriele
Izdano u Cancers (Basel) (2019)

Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis

od Jeong, Gwang Hun, Lee, Keum Hwa, Kim, Jong Yeob, Eisenhut, Michael, Kronbichler, Andreas, van der Vliet, Hans J., Shin, Jae Il, Gamerith, Gabriele
Izdano u J Clin Med (2020)

A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies

od Goedegebuure, Ruben S.A., Wentink, Madelon Q., van der Vliet, Hans J., Timmerman, Peter, Griffioen, Arjan W., de Gruijl, Tanja D., Verheul, Henk M.W.
Izdano u Oncologist (2020)

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function

od Veluchamy, John P., Delso-Vallejo, María, Kok, Nina, Bohme, Fenna, Seggewiss-Bernhardt, Ruth, van der Vliet, Hans J., de Gruijl, Tanja D., Huppert, Volker, Spanholtz, Jan
Izdano u Sci Rep (2017)

Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis

od Jeong, Gwang Hun, Lee, Keum Hwa, Kim, Jong Yeob, Eisenhut, Michael, Kronbichler, Andreas, van der Vliet, Hans J., Hong, Sung Hwi, Shin, Jae Il, Gamerith, Gabriele
Izdano u J Clin Med (2019)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

od Veluchamy, John Pradeep, Spanholtz, Jan, Tordoir, Marleen, Thijssen, Victor L., Heideman, Daniëlle A. M., Verheul, Henk M. W., de Gruijl, Tanja D., van der Vliet, Hans J.
Izdano u PLoS One (2016)

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

od Huijts, Charlotte M, Santegoets, Saskia J, van den Eertwegh, Alfons J, Pijpers, Laura S, Haanen, John B, de Gruijl, Tanja D, Verheul, Henk M, van der Vliet, Hans J
Izdano 2011

Ex vivo Analysis of Resident Hepatic Pro-inflammatory CD1d-reactive T cells & Hepatocyte Surface CD1d Expression in Hepatitis C

od Yanagisawa, Kazuhiko, Yue, Simon, van der Vliet, Hans J., Wang, RuoJie, Alatrakchi, Nadia, Golden-Mason, Lucy, Schuppan, Detlef, Koziel, Margaret J., Rosen, Hugo R., Exley, Mark A.
Izdano 2013